Table 1 Clinicopathological characteristics of the patient cohorts.
From: ATP6AP1 as a potential prognostic biomarker in CRC by comprehensive analysis and verification
Characteristic | READ (n = 29) | COAD (n = 29) | ||||
|---|---|---|---|---|---|---|
Low expression of ATP6AP1 | High expression of ATP6AP1 | P-value | Low expression of ATP6AP1 | High expression of ATP6AP1 (n = 239) | P-value | |
(n = 83) | (n = 83) | (n = 239) | ||||
T stage, n (%) | Â | Â | 0.093 | Â | Â | 0.941 |
 T1 | 6 (3.7%) | 3 (1.8%) |  | 5 (1%) | 6 (1.3%) |  |
 T2 | 9 (5.5%) | 19 (11.6%) |  | 42 (8.8%) | 41 (8.6%) |  |
 T3 | 61 (37.2%) | 52 (31.7%) |  | 163 (34.2%) | 160 (33.5%) |  |
 T4 | 5 (3%) | 9 (5.5%) |  | 28 (5.9%) | 32 (6.7%) |  |
N stage, n (%) | Â | Â | 0.305 | Â | Â | 0.05 |
 N0 | 39 (24.1%) | 45 (27.8%) |  | 155 (32.4%) | 129 (27%) |  |
 N1 | 20 (12.3%) | 25 (15.4%) |  | 48 (10%) | 60 (12.6%) |  |
 N2 | 20 (12.3%) | 13 (8%) |  | 36 (7.5%) | 50 (10.5%) |  |
M stage, n (%) | Â | Â | 0.945 | Â | Â | 0.003 |
 M0 | 59 (39.6%) | 67 (45%) |  | 184 (44.3%) | 165 (39.8%) |  |
 M1 | 10 (6.7%) | 13 (8.7%) |  | 21 (5.1%) | 45 (10.8%) |  |
Age, median (IQR) | 64 (56, 71.5) | 66 (59, 74.5) | 0.035 | 69 (60, 78) | 68 (57, 77) | 0.325 |
